Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation

BMC Medical Genomics

Volumn 2, Issue , 2009, Pages

  Martin, Maureen V ^a   Rollins, Brandi ^a   Sequeira, P Adolfo ^a   Mesén, Andrea ^b,c   Byerley, William ^d   Stein, Richard ^a   Moon, Emily A ^a   Akil, Huda ^e   Jones, Edward G ^f   Watson, Stanley J ^e   Barchas, Jack ^g   DeLisi, Lynn E ^h   Myers, Richard M ⁱ   Schatzberg, Alan ^j   Bunney, William E ^a   Vawter, Marquis P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Psychiatric Genetics Research Center   (Costa Rica)

^c Hospital Nacional Psiquiatrico   (Costa Rica)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Department of Obstetrics Gynecology   (United States)

^h NEW YORK UNIVERSITY   (United States)

ⁱ Stanford University ^*  (United States)

^j STANFORD UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INTERFERON REGULATORY FACTOR 5;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EXON; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PREFRONTAL CORTEX; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; BRAIN; CELL LINE; CYTOLOGY; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADULT; BRAIN; CELL LINE, TRANSFORMED; EXONS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLUCOSE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 70350028330     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-2-62     Document Type: Article

References (61)

1. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Y Hakak JR Walker C Li WH Wong KL Davis JD Buxbaum V Haroutunian AA Fienberg, Proc Natl Acad Sci USA 2001 98 8 4746 4751 10.1073/pnas.081071198 11296301
2. Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders. J Pongrac FA Middleton DA Lewis P Levitt K Mirnics, Neurochem Res 2002 27 10 1049 1063 10.1023/A:1020904821237 12462404
3. Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree. MP Vawter E Ferran B Galke K Cooper WE Bunney W Byerley, Schizophr Res 2004 67 1 41 52 10.1016/S0920-9964(03)00151-8 14741323
4. Mitochondria, synaptic plasticity, and schizophrenia. D Ben-Shachar D Laifenfeld, Int Rev Neurobiol 2004 59 273 296 full-text 15006492
5. Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. K Mirnics FA Middleton DA Lewis P Levitt, Trends Neurosci 2001 24 8 479 486 10.1016/S0166-2236(00)01862-2 11476888
6. Genome scans and gene expression microarrays converge to identify gene regulatory loci relevant in schizophrenia. MP Vawter ME Atz BL Rollins KM Cooper-Casey L Shao WF Byerley, Hum Genet 2006 119 5 558 570 10.1007/s00439-006-0172-7 16604350
7. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. FA Middleton K Mirnics JN Pierri DA Lewis P Levitt, J Neurosci 2002 22 7 2718 2729 11923437
8. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. S Prabakaran JE Swatton MM Ryan SJ Huffaker JT Huang JL Griffin M Wayland T Freeman F Dudbridge KS Lilley, et al. Mol Psychiatry 2004 9 7 684 697 10.1038/sj.mp.4001532 15098003 (Pubitemid 38932173)
9. Insulin, IGF-1, and muscarinic agonists modulate schizophrenia-associated genes in human neuroblastoma cells. CA Altar RA Hunt LW Jurata MJ Webster E Derby P Gallagher A Lemire J Brockman P Laeng, Biol Psychiatry 2008 64 12 1077 1087 10.1016/j.biopsych.2008.08.031 18973876
10. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. MT Tsuang N Nossova T Yager MM Tsuang SC Guo KG Shyu SJ Glatt CC Liew, Am J Med Genet B Neuropsychiatr Genet 2005 133 1 1 5
11. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. F Borovecki L Lovrecic J Zhou H Jeong F Then HD Rosas SM Hersch P Hogarth B Bouzou RV Jensen, et al. Proc Natl Acad Sci USA 2005 102 31 11023 11028 10.1073/pnas.0504921102 16043692
12. Blood gene expression profiling of neurologic diseases: a pilot microarray study. Y Tang DL Gilbert TA Glauser AD Hershey FR Sharp, Arch Neurol 2005 62 2 210 215 10.1001/archneur.62.2.210 15710849
13. Gene expression profile analysis of lymphocytes from Alzheimer's patients. J Klmn K Kitajka M Pkski Á Zvara A Juhsz G Vincze Z Janka L Pusks, Psychiatric Genetics 2005 15 1 6 10.1097/00041444-200503000-00001 15722950
14. Peripheral blood gene expression signature mirrors central nervous system disease: The model of multiple sclerosis. A Achiron M Gurevich, Autoimmunity Reviews 2006 5 517 522 10.1016/j.autrev.2006.02.009 17027885
15. Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. RH Segman N Shefi T Goltser-Dubner N Friedman N Kaminski AY Shalev, Mol Psychiatry 2005 10 5 500 513 425. 10.1038/sj.mp.4001636 15685253 (Pubitemid 40646438)
16. Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. OC Maes S Xu B Yu HM Chertkow E Wang HM Schipper, Neurobiol Aging 2007 28 12 1795 1809 10.1016/j.neurobiolaging.2006.08.004 16979800
17. Gene expression microarray studies in polygenic psychiatric disorders: applications and data analysis. C Konradi, Brain Res Brain Res Rev 2005 50 1 142 155 10.1016/j.brainresrev.2005.05.004 15964635
18. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. SJ Glatt IP Everall WS Kremen J Corbeil R Sasik N Khanlou M Han CC Liew MT Tsuang, Proc Natl Acad Sci USA 2005 102 43 15533 15538 10.1073/pnas.0507666102 16223876
19. Evaluating the comparability of gene expression in blood and brain. PF Sullivan C Fan CM Perou, Am J Med Genet B Neuropsychiatr Genet 2006 141B 3 261 268 10.1002/ajmg.b.30272 16526044
20. Differences in lymphocytes electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress. A Naydenov B MacDonald D Ongur C Konradi, Archives of General Psychiatry 2007 64 555 564 10.1001/archpsyc.64.5.555 17485607
21. Schizophrenia: a neural diathesis-stress model. EF Walker D Diforio, Psychol Rev 1997 104 4 667 685 10.1037/0033-295X.104.4.667 9337628
22. Effects of metabolic perturbation on plasma homovanillic acid in schizophrenia. Relationship to prefrontal cortex volume. A Breier OR Davis RW Buchanan LA Moricle RC Munson, Arch Gen Psychiatry 1993 50 7 541 550 8317948
23. Effect of acute metabolic stress on pituitary-adrenal axis activation in patients with schizophrenia. I Elman CM Adler AK Malhotra C Bir D Pickar A Breier, Am J Psychiatry 1998 155 7 979 981 9659871
24. Comparison of smoking-induced gene expression on Affymetrix Exon and 3'-based expression arrays. X Zhang G Liu ME Lenburg A Spira, Genome Inform 2007 18 247 257 full-text 18546492
25. Exon arrays provide accurate assessments of gene expression. K Kapur Y Xing Z Ouyang WH Wong, Genome Biol 2007 8 5 82 10.1186/gb-2007-8-5-r82 17504534
26. Clinical characteristics of schizophrenia in multiply affected Spanish origin families from Costa Rica. LE DeLisi A Mesen C Rodriguez A Bertheau B LaPrade M Llach S Riondet K Razi, Psychiatr Genet 2001 11 3 145 152 10.1097/00041444-200109000-00006 11702056
27. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. RA Irizarry B Hobbs F Collin YD Beazer-Barclay KJ Antonellis U Scherf TP Speed, Biostatistics 2003 4 2 249 264 10.1093/biostatistics/4.2.249 12925520
28. A genome-wide association study of global gene expression. AL Dixon L Liang MF Moffatt W Chen S Heath KC Wong J Taylor E Burnett I Gut M Farrall, et al. Nat Genet 2007 39 10 1202 1207 10.1038/ng2109 17873877
29. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. MF Moffatt M Kabesch L Liang AL Dixon D Strachan S Heath M Depner A von Berg A Bufe E Rietschel et al. Nature 2007 448 7152 470 473 10.1038/nature06014 17611496
30. Mapping complex disease traits with global gene expression. W Cookson L Liang G Abecasis M Moffatt M Lathrop, Nature Reviews Genetics 2009 10 184 194 19223927 10.1038/nrg2537
31. The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. FM Benes D Matzilevich RE Burke J Walsh, Mol Psychiatry 2006 11 3 241 251 10.1038/sj.mp.4001758 16288314
32. Comparison of false discovery rate methods in identifying genes with differential expression. HR Qian S Huang, Genomics 2005 86 4 495 503 10.1016/j.ygeno.2005.06.007 16054333
33. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. RR Graham C Kyogoku S Sigurdsson IA Vlasova LR Davies EC Baechler RM Plenge T Koeuth WA Ortmann G Hom, et al. Proc Natl Acad Sci USA 2007 104 16 6758 6763 10.1073/pnas.0701266104 17412832
34. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. JM Johnson J Castle P Garrett-Engele Z Kan PM Loerch CD Armour R Santos EE Schadt R Stoughton DD Shoemaker, Science 2003 302 5653 2141 2144 10.1126/science.1090100 14684825
35. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. F Faul E Erdfelder AG Lang A Buchner, Behav Res Methods 2007 39 2 175 191 17695343
36. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. MC Ryan P Collins JH Thakore, Am J Psychiatry 2003 160 2 284 289 10.1176/appi.ajp.160.2.284 12562574
37. Evidence for linkage between regulatory enzymes in glycolysis and schizophrenia in a multiplex sample. WS Stone SV Faraone J Su SI Tarbox P Van Eerdewegh MT Tsuang, Am J Med Genet B Neuropsychiatr Genet 2004 127B 1 5 10 10.1002/ajmg.b.20132 15108172
38. Glucose effects on cognition in schizophrenia. WS Stone LJ Seidman JD Wojcik AI Green, Schizophr Res 2003 62 1-2 93 103 10.1016/S0920-9964(02)00406-1 12765749
39. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. MP Vawter H Tomita F Meng B Bolstad J Li S Evans P Choudary M Atz L Shao C Neal, et al. Mol Psychiatry 2006 11 7 663 679 10.1038/sj.mp.4001830 (Pubitemid 43989813)
40. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. K Iwamoto M Bundo T Kato, Hum Mol Genet 2005 14 2 241 253 10.1093/hmg/ddi022 15563509
41. Application of cDNA microarrays to examine gene expression differences in schizophrenia. MP Vawter T Barrett C Cheadle BP Sokolov WH Wood 3rd DM Donovan M Webster WJ Freed KG Becker, Brain Res Bull 2001 55 5 641 650 10.1016/S0361-9230(01)00522-6 11576761
42. Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia. EG Bruneau RE McCullumsmith V Haroutunian KL Davis JH Meador-Woodruff, Schizophr Res 2005 75 1 27 34 10.1016/j.schres.2004.12.012 15820321
43. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients. MR Gluck RG Thomas KL Davis V Haroutunian, Am J Psychiatry 2002 159 7 1165 1173 10.1176/appi.ajp.159.7.1165 12091195
44. Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. HM Gurling G Kalsi J Brynjolfson T Sigmundsson R Sherrington BS Mankoo T Read P Murphy E Blaveri A McQuillin, et al. Am J Hum Genet 2001 68 3 661 673 10.1086/318788 11179014
45. Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins. C Ling P Poulsen E Carlsson M Ridderstrale P Almgren J Wojtaszewski H Beck-Nielsen L Groop A Vaag, J Clin Invest 2004 114 10 1518 1526 15546003
46. Maturity-onset diabetes of the young resulting from a novel mutation in the HNF-4alpha gene. K Hara M Noda H Waki K Tobe T Yamauchi H Kadowaki H Satou K Tsukamoto S Nagamatsu K Yamagata, et al. Intern Med 2002 41 10 848 852 10.2169/internalmedicine.41.848 12413008
47. Common variants of the hepatocyte nuclear factor-4alpha P2 promoter are associated with type 2 diabetes in the U.K. population. MN Weedon KR Owen B Shields G Hitman M Walker MI McCarthy LD Love-Gregory MA Permutt AT Hattersley TM Frayling, Diabetes 2004 53 11 3002 3006 10.2337/diabetes.53.11.3002 15504983
48. HNF-4alpha: from MODY to late-onset type 2 diabetes. RK Gupta KH Kaestner, Trends Mol Med 2004 10 11 521 524 10.1016/j.molmed.2004.09.004 15519277
49. Evidence of altered calmodulin immunoreactivity in areas 9 and 32 of schizophrenic prefrontal cortex. K Broadbelt LB Jones, J Psychiatr Res 2008 42 8 612 621 10.1016/j.jpsychires.2007.07.006 18289558
50. Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. PR Maycox F Kelly A Taylor S Bates J Reid R Logendra MR Barnes C Larminie N Jones M Lennon, et al. Mol Psychiatry 2009 19255580
51. Estimating genome-wide copy number using allele-specific mixture models. W Wang B Carvalho ND Miller J Pevsner A Chakravarti RA Irizarry, J Comput Biol 2008 15 7 857 866 10.1089/cmb.2007.0148 18707534
52. A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. M Sultan MH Schulz H Richard A Magen A Klingenhoff M Scherf M Seifert T Borodina A Soldatov D Parkhomchuk, et al. Science 2008 321 5891 956 960 10.1126/science.1160342 18599741
53. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. NC Allen S Bagade MB McQueen JP Ioannidis FK Kavvoura MJ Khoury RE Tanzi L Bertram, Nat Genet 2008 40 7 827 834 10.1038/ng.171 18583979
54. Mitochondrial reactive oxygen species are obligatory signals for glucose-induced insulin secretion. C Leloup C Tourrel-Cuzin C Magnan M Karaca J Castel L Carneiro AL Colombani A Ktorza L Casteilla L Penicaud, Diabetes 2009 58 3 673 681 10.2337/db07-1056 19073765
55. Common polymorphic transcript variation in human disease. HB Fraser X Xie, Genome Res 2009 19 4 567 575 10.1101/gr.083477.108 19189928
56. Switching from repression to activation: microRNAs can up-regulate translation. S Vasudevan Y Tong JA Steitz, Science 2007 318 5858 1931 1934 10.1126/science.1149460 18048652
57. MicroInspector: a web tool for detection of miRNA binding sites in an RNA sequence. V Rusinov V Baev IN Minkov M Tabler, Nucleic Acids Res 2005 33 Web Server 696 700 10.1093/nar/gki364 15980566
58. Dose effect of smoking on aberrant methylation in non-small cell lung cancers. S Toyooka M Suzuki T Tsuda KO Toyooka R Maruyama K Tsukuda Y Fukuyama T Iizasa T Fujisawa N Shimizu, et al. Int J Cancer 2004 110 3 462 464 10.1002/ijc.20125 15095316
59. Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation. E Dong M Nelson DR Grayson E Costa A Guidotti, Proc Natl Acad Sci USA 2008 105 36 13614 13619 10.1073/pnas.0805493105 18757738
60. Cigarette smoke induces demethylation of prometastatic oncogene synuclein-gamma in lung cancer cells by downregulation of DNMT3B. H Liu Y Zhou SE Boggs SA Belinsky J Liu, Oncogene 2007 26 40 5900 5910 10.1038/sj.onc.1210400 17369845
61. Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. A Sawa GW Wiegand J Cooper RL Margolis AH Sharp JF Lawler Jr JT Greenamyre SH Snyder CA Ross, Nat Med 1999 5 10 1194 1198 10.1038/13518 10502825